Concepedia

Jiang Liu

JL

Statistics

Publications

22

Citations

2.2K

H-Index

19

Active since

2004

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

University of California, San Francisco

Midwestern University

SciGenom Labs (India)

Jiang Liu is an author at United States Food and Drug Administration specializing in medicine, pharmacotherapy, and pharmacology.

ORCID

Top concepts

Publications per year

2004–2024

22

Publications

22

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Aviva C. Krauss, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2018 · 315 citations · Full text

FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia

Kelly J. Norsworthy, Chia‐Wen Ko, Jee Eun Lee et al. · The Oncologist · 2018 · 240 citations · Full text

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2

Kushal Suryamohan, Devan Diwanji, Eric Stawiski et al. · Communications Biology · 2021 · 229 citations · Full text

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Sandra J. Casak, Martha Donoghue, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2020 · 170 citations

FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1

Preeti Narayan, Sakar Wahby, Jennifer Gao et al. · Clinical Cancer Research · 2020 · 164 citations

, , +17

1–5 of 22